Susan O'Brien

17PUBLICATIONS
71CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 12, 2025
Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL.

John N Allan, Tao Ran, Zhijie Ding

|Aug 21, 2024
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies.

Pinkal Desai, Sagar Lonial, Amanda Cashen

|Apr 12, 2024
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.

Yaqi Zhao, A Douglas Laird, Kathryn G Roberts

|Nov 07, 2023
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Jun 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.

Jennifer A Woyach, Paolo Ghia, John C Byrd

|Apr 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change.

Benjamin J Lee, Piyanuch Kongtim, Jean Doh

Pageof 3

Frequent Collaborators

5 joint publications

Jean Doh

5 joint publications

Benjamin J Lee

5 joint publications

Alexandre Chan

5 joint publications

Deepa Jeyakumar